Results 111 to 120 of about 46,812 (206)

Better drugs for Lyme disease: focus on the spirochete

open access: yes, 2018
Raphael B Stricker,1 Marianne J Middelveen2 1Union Square Medical Associates, San Francisco, CA, USA; 2Atkins Veterinary Services, Calgary, AB, Canada Abstract: Twenty-five years ago, the AIDS epidemic was wreaking havoc around the world. Although “
Stricker RB, Middelveen MJ
core  

Chronic Lyme disease: misconceptions and challenges for patient management

open access: yes, 2015
John J HalperinDepartment of Neurosciences, Overlook Medical Center, Summit, NJ, USAAbstract: Lyme disease, infection with the tick-borne spirochete Borrelia burgdorferi, causes both specific and nonspecific symptoms.
Halperin JJ
core  

The current landscape and future directions of Lyme disease vaccines. [PDF]

open access: yesVirulence
Chen Z   +5 more
europepmc   +1 more source

A poetic narrative inquiry into the lives of people with Lyme disease

open access: yes, 2018
Stories of people becoming critically ill with Lyme disease are finally starting to emerge within communities and social arenas. For many, there is a sigh of relief, and for others, there is a sense of confusion and concern.
Baize-Ward, Amy Michelle
core  

Imported Pediatric Lyme Disease in Singapore-A Case Series. [PDF]

open access: yesPathogens
Tan AXN   +5 more
europepmc   +1 more source

Lyme Disease Presenting as Rupture Baker's Cyst: Case Report and Literature Review. [PDF]

open access: yesClin Med Insights Case Rep
Ghali A   +5 more
europepmc   +1 more source

Lyme\u27s Disease: Neurologic and Neuro-Ophthalmic Syndromes

open access: yes, 1990
Lyme disease is a multisystem disorder, heralded by a pathognomonic rash and characterized by prominent dermatologic, neurologic, cardiac and meumatologic manifestations.
Jacqueline Winterkorn, MD, PhD (1947-2015)
core  

Predicting Lyme Disease: A One Health Approach. [PDF]

open access: yesPathogens
McDermott M   +6 more
europepmc   +1 more source

Notes from the Field: Borrelia mayonii Lyme Disease - New York, 2025. [PDF]

open access: yesMMWR Morb Mortal Wkly Rep
Nafiz TN   +6 more
europepmc   +1 more source

Lyme disease control 2.0: Advances and opportunities coming with Lyme disease vaccine VLA15. [PDF]

open access: yesPLoS Pathog
Hajdusek O   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy